Our results provide new cellular and molecular evidence to understand why individuals with TET2-derived CH have an increased risk to develop neutrophil-associated pathologies such as severe microbial infections, cardiovascular diseases, and COPD.33 Here, TET2 is linked to cyclic hematopoiesis.